Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy

被引:9
|
作者
Nevedal, Andrea L. [1 ]
Timko, Christine [2 ,3 ]
Lor, Mai Chee [2 ]
Hoggatt, Katherine J. [4 ,5 ]
机构
[1] VA Ctr Clin Management Res, Dept Vet Affairs Hlth Care Syst, Ann Arbor, MI 48105 USA
[2] Ctr Innovat Implementat, Dept Vet Affairs Hlth Care Syst, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[4] San Francisco VA Hlth Care Syst, San Francisco, CA USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
opioids; tapering; veterans; patients; providers; qualitative methods; long-term opioid therapy; COMPLEMENTARY;
D O I
10.1007/s11606-022-07880-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Given efforts to taper patients off long-term opioid therapy (LTOT) because of known harms, it is important to understand if patients and providers align in LTOT treatment goals. Objective To investigate patient and provider perceptions about the harms and benefits of continuing and discontinuing LTOT. Design Qualitative study Participants Patients and providers with experiences with LTOT for pain in two Veterans Health Affairs regions. Approach We conducted semi-structured interviews and analyzed data using rapid qualitative analysis to describe patient and provider preferences about LTOT continuation and discontinuation and non-opioid pain treatments. Key Results Participants (n=43) included 28/67 patients and 15/17 providers. When discussing continuing LTOT, patients emphasized the benefits outweighed the harms, whereas providers emphasized the harms. Participants agreed on the benefits of continuing LTOT for improved physical functioning. Provider-reported benefits of continuing LTOT included maintaining the status quo for patients without opioid alternatives or who were at risk for illicit drug use. Participants were aligned regarding the harms of negative side-effects (e.g., constipation) from continued LTOT. In contrast, when discussing LTOT tapering and discontinuation, providers underscored how benefits outweighed the harms, citing patients' improved well-being and pain management with tapering or alternatives. Patients did not foresee benefits to potential LTOT tapers or discontinuation and were worried about pain management in the absence of LTOT. When discussing non-opioid pain treatments, participants emphasized that they were adjunctive to opioid therapy rather than a replacement (except for cannabis). Providers described the importance of mental health services to manage pain, which differed from patients who focused on treatments to improve strength and mobility and reduce pain. Conclusions Patients emphasized the benefits of continuing LTOT for pain management and well-being, which differed from providers' emphasis on the benefits of discontinuing LTOT. Patient and provider differences are important for informing patient-centered care and decisions around continuing, tapering, or discontinuing LTOT.
引用
收藏
页码:1802 / 1811
页数:10
相关论文
共 50 条
  • [1] Patient and Provider Perspectives on Benefits and Harms of Continuing, Tapering, and Discontinuing Long-Term Opioid Therapy
    Andrea L. Nevedal
    Christine Timko
    Mai Chee Lor
    Katherine J. Hoggatt
    Journal of General Internal Medicine, 2023, 38 : 1802 - 1811
  • [2] Tapering Long-Term Opioid Therapy
    Lembke, Anna
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (01) : 49 - 52
  • [3] Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy
    Sehgal, Nalini
    Colson, James
    Smith, Howard S.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (11) : 1201 - 1220
  • [4] "WHAT'S THE DIFFERENCE OF ONE MORE PILL?" PATIENT PERSPECTIVES ON RISKS AND BENEFITS OF CONTINUING AND TAPERING CHRONIC OPIOID THERAPY
    Perez, Hector R.
    Prinz, Melanie
    Buonora, Michele
    Starrels, Joanna L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S330 - S330
  • [5] Management of patients at risk of harms from both continuing and discontinuing their long-term opioid therapy: A qualitative study to inform the gap in clinical practice guidelines
    Timko, Christine
    Lor, Mai Chee
    Kertesz, Stefan
    Kroenke, Kurt
    Macia, Kathryn
    Nevedal, Andrea
    Hoggatt, Katherine J.
    PAIN PRACTICE, 2025, 25 (01)
  • [6] Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering
    Kosakowski, Sarah
    Benintendi, Allyn
    Lagisetty, Pooja
    Larochelle, Marc R.
    Bohnert, Amy S. B.
    Bazzi, Angela R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (07) : 1722 - 1728
  • [7] Dose Tapering in Women Prescribed Long-Term Opioid Therapy
    Agnoli, Alicia L.
    Franks, Peter
    Xing, Guibo
    Tancredi, Daniel J.
    Fenton, Joshua J.
    JOURNAL OF WOMENS HEALTH, 2022, 31 (10) : A15 - A15
  • [8] Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering
    Sarah Kosakowski
    Allyn Benintendi
    Pooja Lagisetty
    Marc R. Larochelle
    Amy S. B. Bohnert
    Angela R. Bazzi
    Journal of General Internal Medicine, 2022, 37 : 1722 - 1728
  • [9] The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary
    Manhapra, Ajay
    Arias, Albert J.
    Ballantyne, Jane C.
    SUBSTANCE ABUSE, 2018, 39 (02) : 152 - 161
  • [10] EFFECTS OF DISCONTINUING LONG-TERM OPIOID THERAPY IN PATIENTS WITH CHRONIC PAIN
    Husain, Jawad M.
    Larochelle, Marc
    Keosaian, Julia
    Gamble, Olivia
    Xuan, Ziming
    Lasser, Karen E.
    Liebschutz, Jane M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S175 - S175